Sacramento, CA, United States of America

William Blaisdell

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 204(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of William Blaisdell

Introduction

William Blaisdell is a notable inventor based in Sacramento, California. He has made significant contributions to the field of medical technology, particularly in the area of intraosseous infusions. His work has the potential to improve patient care and enhance medical procedures.

Latest Patents

William Blaisdell holds a patent for a "Method and apparatus for intraosseous infusions." This innovative apparatus and related method allow for the infusion of liquids and drugs into, or the aspiration of marrow from, the trabecula of a patient's bone. The design enables users to reliably determine when an enlarged, threaded tip of an infusion/aspiration tube has reached the trabecular bone. Additionally, a spring bias ensures that the tip seals the hole formed in cortical bone during subsequent infusions or aspirations. He has 1 patent to his name.

Career Highlights

Blaisdell is affiliated with the University of California, where he continues to contribute to research and development in medical technologies. His work is characterized by a commitment to improving medical procedures and patient outcomes.

Collaborations

Some of his notable coworkers include George C. Kramer and Jerald M. Henderson. Their collaborative efforts have further advanced the field of medical technology.

Conclusion

William Blaisdell's innovative work in intraosseous infusions exemplifies the impact of dedicated inventors in the medical field. His contributions are paving the way for advancements that can significantly enhance patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…